Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-10-02 01:08:29 - browse：2983

A group of four doctors gather around a hologram projecting different medical icons — health tech coverage from STAT — Adobe

DarioHealth, which makes apps for managing chronic diseases, today announced it will acquire digital mental health company Twill for $10 million in cash plus stock valued at over $20 million at the end of Tuesday trading. The move is a bet that a consolidated offering can attract a critical mass of large customers in a market where profits have been elusive.

Founded in 2011, Dario started with a diabetes app targeted at consumers before expanding it to hypertension and weight management. It still maintains that direct-to-consumer business but has since shifted its focus to selling its suite of offerings, including a musculoskeletal care program it acquired in 2021, to health plans and employers in the hopes of reaching much larger patient populations. Recent updates aimed at making itself attractive to clients include a new offering built around popular, and expensive, GLP-1 weight loss drugs, and published real world data suggesting its tools can save clients money on downstream health care costs. With Twill, Dario adds a mental health app and related services, addressing a top demand of employers.

Despite momentum, DarioHealth, which is publicly traded, is unprofitable, and by its own estimations on earnings calls last year, it remained a ways from that milestone. Before acquiring Twill, the company said that it expected the whole business to break even at about $80 million in revenue — about four times the roughly $20 million it projected for 2023. In November, the company reported that it lost over $40 million in the first nine months of 2023.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： France's anti

explore

WSS

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

AdventHealth escalates lawsuit against insurance vendor Multiplan

Antibody drugs appear effective. Now can we make enough of them?

Sickle cell gene therapy cures need to be accessible in Africa

Sickle cell gene therapy cures need to be accessible in Africa

One Duchenne patient's bittersweet hope for new treatment

knowledge

Wikipedia

hotspot

Bright Health sells Medicare Advantage business to Molina

Antibody drugs appear effective. Now can we make enough of them?

Peter Hotez and the public health issue of online harassment

Burning questions for the 2024 JPM Healthcare Conference

United colonoscopy coverage change 'may cost lives,' doctors say

France's anti

Medicare proposal to cover medical devices draws a mixed reaction

Grail's uphill battle for Medicare to cover its cancer screening test

Anesthesiologist group: stop taking Ozempic before surgery

The debate over Covid

explore

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

New weight loss drugs work. But how can they best be used?

After half a century, Israel moves to evict squatter from his cave home on the beach

Why psychiatrists like me stop taking insurance

Vermont grapples with historic flooding as more rainstorms head for Northeast

The FDA must approve intranasal treatments for anaphylaxis

entertainment

explore

explore

leisure time